CORRESP Filing
ORAGENICS INC
Date: June 26, 2025 · CIK: 0001174940 · Accession: 0001641172-25-016704
AI Filing Summary & Sentiment
File numbers found in text: 333-288225
Show Raw Text
CORRESP 1 filename1.htm DAWSON JAMES SECURITIES INC. 101 North Federal Highway Suite 600 Boca Raton, Fl 33432 June 26, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-3628 Attn: Lauren Hamill, Division of Corporation Finance Re: Oragenics, Inc. (the "Company") Registration Statement on Form S-1 File No. 333-288225 Request for Acceleration Dear Ms. Hamill: Dawson James Securities Inc., the placement agent in the offering contemplated in the Registration Statement referenced above, hereby requests, pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, that the effective date of the above referenced Registration Statement on Form S-1 be accelerated so that it will be declared effective at 4:30 p.m., Eastern Time, on June 30, 2025 or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please confirm that event with Julio Esquivel, of Shumaker, Loop & Kendrick, LLP, at (813) 227-2325. Very truly yours, DAWSON JAMES SECURITIES INC. By: /s/ Robert D. Keyser, Jr. Name: Robert D. Keyser, Jr. Title: Chief Executive Officer